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Early in apoptosis, ceramide levels rise and the mito-
chondrial outer membrane becomes permeable to small
proteins. The self-assembly of ceramide to form channels
could be the means by which intermembrane space pro-
teins are released to induce apoptosis. Dihydroceramide
desaturase converts dihydroceramide to ceramide. This
conversion may be removing an inhibitor as well as
generating a pro-apoptotic agent. We report that both long
and short chain dihydroceramides inhibit ceramide channel
formation in mitochondria. One tenth as much dihydroce-
ramide was sufficient to inhibit the permeabilization of the
outer membrane by about 95% (C2) and 51% (C16). Similar
quantities inhibited the release of carboxyfluorescein from
liposomes indicating that other mitochondrial components
are not necessary for the inhibition. The apoptogenic
activity of ceramide may thus depend on the ceramide to
dihydroceramide ratio resulting in a more abrupt transition
from the normal to the apoptotic state when the de novo
pathway is used in mitochondria.
Keywords: ceramide channels; ceramide-induced apoptosis; cy-
tochrome c release; de novo synthesis; dihydroceramide; lipo-
somes; mitochondria.
Abbreviations: CF: carboxyfluorescein; C2-ceramide:
N-acetyl-D-erythro-sphingosine; C16-ceramide: N-palmitoyl-D-
erythro-sphingosine; DHC2: N-acetyl-D-erythro-sphinganine or
C2-dihydroceramide; DHC16: N-palmitoyl-erythro-sphinganine or
C16-dihydroceramide; DPX: p-xylene-bis-pyridinium bromide.
Introduction
Ceramides are sphingosine-based lipids that normally ex-
ist in cell membranes at a steady state level. This level is
increased in cells undergoing apoptosis (for review, see1–3)
and this increase is thought to be an important step in the
apoptotic process.
Ceramide’s role in apoptosis is quite extensive and di-
verse. It has been proposed that ceramide induces apoptosis
via several routes. For instance, by clustering into ceramide-
enriched domains in the plasma membrane, ceramide is able
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to recruit or cluster Fas receptors to induce Fas-mediated
apoptosis.4–7 Ceramide is also believed to be involved in re-
organizing small membrane rafts into signaling platforms in
response to stress. The control seems to arise from ceramide
locally generated within rafts (for review, see8). Ceramide
administration changed the phosphorylation states of some
MAP kinases9–13 and since this coincides with the release of
cytochrome c, AIF, SMAC, and Omi from mitochondria this
change in phosphorylation state is believed to be causal.13 In
differentiating embryonic stem cells, ceramide is reported
to mediate the binding of protein kinase C zeta (PKC ζ ) to
its inhibitor PAR-4 (prostate apoptosis response-4) and this
is proposed to be responsible for the induction of apoptosis
in these cells.14
Ceramide could also initiate apoptosis by permeabilizing
the mitochondrial outer membrane to pro-apoptotic pro-
teins found in the intermembrane space. The release of these
proteins into the cytosol has been shown to be a critical
step in committing a cell to irreversible apoptosis. This
permeabilization can be performed by ceramide directly be-
cause both short chain (C2) and long chain (C16) ceramides
form channels in planar phospholipid membranes15 and in
liposomes (this study). The addition of ceramide to whole
cell cultures induces the release of cytochrome c into the
cytosol.16–19 Ceramide also induces the release of cytochrome
c in isolated mitochondria.20–22 The permeability of the mi-
tochondrial outer membrane to proteins can be enhanced
in a dose- and time-dependent fashion by incubation with
ceramide.23 This permeability showed a molecular weight
cutoff of 60 kDa.23 This is an appropriate size for releasing
the known pro-apoptotic proteins from the mitochondrial
intermembrane space.
Dihydroceramide is almost identical to ceramide except
that it lacks a critical trans double bond at the 4, 5 position.
It is an intermediate in the de novo synthesis pathway and is
believed to be biologically inactive in that it cannot cause
cells to undergo apoptosis24,25 nor can it induce the release
of cytochrome c when added to isolated mitochondria23 or
cell cultures. Dihydroceramide also does not form channels
in planar phospholipid membranes15 or in liposomes (this
study). However, rather than simply being inactive, we pro-
vide evidence that it can be inhibitory. Indeed we find that
both C2- and C16-dihydroceramide interfere with ceramide
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channel formation both in mitochondria and in liposomes.
Generation of ceramide by the de novo pathway involves
converting dihydroceramide to ceramide. Our results indi-
cate that both the process of depleting dihydroceramide and
augmenting ceramide levels are important in the generation
of ceramide channels and the induction of apoptosis. This
combined effect would sharpen the transition from imper-
meability to permeabilization of the outer membrane.
Materials and methods
Materials—Asolectin (polar extract of soybean lipids),
C2-ceramide, C2-dihydroceramide, C16-ceramide and C16-
dihydroceramide were supplied by Avanti Polar Lipids (Al-
abaster, AL). Analytical-grade DMSO (from Fisher) was used
to dissolve C2-ceramide and C2-dihydroceramide whereas
isopropanol (from Acros Organics) was used to dissolve C16-
ceramide and C16-dihydroceramide. 4-Carboxyfluorescein
(CF) and p-xylene-bis-pyridinium bromide (DPX) were ob-
tained from Molecular Probes (Eugene, OR). Cytochrome c
and bovine serum albumin (BSA, fatty acid depleted) and
cholesterol were from Sigma (St. Louis, MO). Sodium ascor-
bate was bought from Acros Organics.
Mitochondria—Mitochondria were isolated from male
Sprague-Dawley rat liver as described by Parsons et al.26
as modified.23 In brief, young rats (generally 200 to 300 g),
fasted overnight with water ad labitum, were decapitated, the
liver excised and cut in ice-cold isolation buffer (210 mM
Mannitol, 70 mM sucrose, 10 mM HEPES, 100 µM EGTA
and 0.05 mg /mL of fatty acid-free Bovine Serum Albu-
min, pH 7.4; i.e. HB-buffer). The liver was minced and
homogenized in a motorized Potter homogenizer with loose
Teflon pestle (two passes). The homogenate was centrifuged
at 760 g for 10 min at 4◦C. The supernatant was then spun
for 10 min at 9000 g to recover mitochondria. This sequence
was repeated but the second high-speed spin was performed
without BSA (H-buffer). Finally the mitochondrial pellet
was resuspended in the isolation buffer without BSA.
The protein concentration of the mitochondrial suspen-
sion was measured by using a spectroscopic method.27 In
short, 25 µL of the suspension was diluted in 475 µL of
H-buffer without BSA. 500 µL of 100 mM Tris: H2SO4,
0.4% SDS pH 8.0 was added to the mitochondrial suspen-
sion and the absorbance measured at 280 nm and 310 nm.
The protein concentration is 40×(A280−A310)1.05 . Reduced cy-
tochrome c was prepared by mixing 11 mg of cytochrome c
with 4 mg sodium ascorbate in 0.5 mL of buffer Q (200 mM
HEPES, 10 mM EGTA, pH 7.5). The reduced cytochrome
c was separated from the ascorbate on a Sephadex G-10 gel
filtration column pre-equilibrated with buffer Q.
The mitochondria (50 µL of 0.2 mg/mL) were sus-
pended in 0.75 mL of isotonic H-medium supplemented
with 2.2 µM antimycin A and 2 mM 2, 4-dinitrophenol and
treated with ceramide or dihydroceramide in different doses.
The permeabilization of the mitochondria was measured by
monitoring the reduction of the absorbance of added reduced
cytochrome c at 550 nm. C2-ceramide and dihydroceramide
were added as 10 µL of a DMSO solution. The dose of ce-
ramide therein was kept the same (2.5 µL of 4 mg/mL or a
total of 29 nmoles) and it was mixed with various amounts of
dihydroceramide and DMSO to achieve the concentrations
of DHC2 used in each experiment. C16-ceramide and dihy-
droceramide were added as 50 µL of an isopropanol solution.
It contained a constant 25 µL of 2 mg/mL C16-ceramide (93
nmoles) diluted with 25 µL of either isopropanol or DHC16
in isopropanol (1 mg/mL) to achieve the desired amount of
dihydroceramide. Vehicle controls were performed as appro-
priate.
Liposomes—Liposomes were made after mixing the lipids
(93% asolectin and 7% cholesterol, by weight) in chloroform
and the solvent was evaporated under nitrogen and overnight
in vacuum. The lipids (total of 5 mg) were hydrated in
a buffer containing 1.5 mM CF 6 mM DPX 38.8 mM
NaCl 10 mM HEPES and 1 mM EDTA pH 7.0. The li-
posomes were vortexed and subjected to 4 cycles of freeze-
thaw-sonication followed by freeze-thawing and extrusion
through a polycarbonate membrane to form uniform single
walled vesicles (100 nm). A Sephacryl S200 gel filtration
column (1.5 × 30 cm) was used to separate the liposomes
from unloaded fluorophore. 100 µL of the liposome sus-
pension (containing approximately 0.1 mg of lipid) were
diluted into 2 mL of 50 mM NaCl, 10 mM HEPES, 1 mM
EDTA pH 7. The liposomes were assessed for their fluores-
cence in a Deltascan spectrofluorometer (Photon Technology
Instruments). CF was excited at 495 nm and the emitted
light detected at 520 nm. The fluorescence was measured
as a function of time and then different concentrations of
C2-ceramide, C16-ceramide or C2-ceramide premixed with
DHC2 were added. The increase in fluorescence was the re-
sult of the release of CF from the liposomes and its dilution
from the quenching agent, DPX. The maximal increase in
fluorescence was measured following the addition of 150 µL
of 5% Triton-X 100.
Results
Ceramide permeabilizes mitochondria and
dihydroceramide blocks this permeabilization
The permeabilization of the outer membrane of isolated rat
liver mitochondria was achieved by measuring the oxida-
tion of exogenously added cytochrome c by mitochondria.
Cytochrome oxidase carries electrons from cytochrome c to
molecular oxygen, thus oxidizing cytochrome c. If the outer
membrane is intact, cytochrome c will not be able to cross
it to get to the cytochrome oxidase. Permeabilization of the
outer membrane to cytochrome c can be detected by the oxi-
dation of cytochrome c measured as a reduction in absorbance
at 550 nm. Incubation of mitochondria with 29 nmoles of
C2- (Figure 1a) or 93 nmoles of C16-ceramide (Figure 1b) for
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Figure 1 Dihydroceramide inhibits the permeabilization of the mito-
chondrial outer membrane by ceramide. The percent of cytochrome
c in the reduced state is plotted as a function of time after the ad-
dition of 29 nmol C2-ceramide, 29 nmol dihydroceramide (DHC2)
and 22 nmol DHC2+29 nmol C2 (panel a), 93 nmol C16, 46 nmol
DHC16 and 46 nmol DHC16+93 nmol C16 (panel b) to 0.75 mL of
mitochondrial suspension (13 µg of mitochondrial protein per mL).
10 min induced a permeability to cytochrome c as evident
by the fast decrease of the level of reduced cytochrome c.
Alternatively, incubating mitochondria with a similar dose
of C2- or C16-dihydroceramide (DHC2 or DHC16) caused
no permeabilization of the mitochondria. The slow decrease
in the reduced cytochrome c after dihydroceramide occurred
at the same rate as untreated mitochondria or mitochondria
treated with DMSO (results not shown; see also23). When
dihydroceramide is premixed with ceramide, the ability of
ceramide to permeabilize mitochondria was effectively re-
duced (Figure 1a and b) and this reduction occurred in a
dose-dependent manner (Figure 2a and b). The amounts of
C2- and C16-ceramides used were chosen to produce close
to maximal effects, hence increasing the signal to noise ra-
tio. These amounts were higher than the physiological lev-
els of ceramide in mitochondria (about 52 pmol C2 per
nmol mitochondrial phospholipid and 168 pmol C16 per
Figure 2 Dihydroceramide reduces ceramide channel formation in
mitochondria. (a) The initial rate of oxidation of cytochrome c, ob-
tained from experiments similar to those shown in Figure 1, is shown
as a function of the amount of DHC2 added to a fixed amount of
C2-ceramide (as indicated). The points collected at 29 nmoles of
DHC2 had no added C2-ceramide. The results were collected in
three different experiments. The amount of mitochondria used in the
experiments 13 µg/mL. The baseline oxidation rate (DMSO alone)
was subtracted from each point. Inset: Low levels of ceramide and
dihydroceramide were used along with a higher mitochondrial pro-
tein concentration (133 µg/mL). (b) A bar graph showing similar
results for the effects of DHC16 on C16-ceramide channel formation.
Again the results were obtained from 3 independent experiments,
hence the large error bars. “Lysed” refers to the rate of cytochrome
c oxidation after hypotonic shock (20 µL of mitochondria were di-
luted to 1.5 mL with water). The results represent the mean of three
experiments±S.D. The level of statistical significance from control
(0 nmol DHC16) is shown with ∗, P ≤0.05.
nmol mitochondrial phospholipid∗). However, under phys-
iological conditions, C2-ceramide channel formation (Fig-
ure 2a inset) was inhibited by DHC2 and C16-ceramide was
also inhibited by DHC16 (data not shown). Moreover, the
∗The calculation is based on the percent insertion of added ceramide
into the mitochondrial membranes.28 For 40 µM C2, about 2 percent
inserts in the membranes. In mitochondria, total phospholipid in the
membranes is about 680 µg phospholipid per mg protein.32
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estimated physiological levels of ceramide needed to initiate
apoptosis are average levels, whereas the local concentration
of ceramide (produced by dihydroceramide desaturase) must
be much higher. Thus the reported influence of dihydro-
ceramide on channel formation should be physiologically
relevant.
Mitochondria were incubated with each of the mixtures
for 10 min and the reaction was started by the addition of
reduced cytochrome c. Pre-incubation with ceramide alone
induced the greatest permeabilization. Premixing ceramide
with dihydroceramide greatly reduced the ceramide-induced
permeabilization. The effect was dose-dependent and even
a small ratio of dihydroceramide to ceramide reduced the
ability of ceramide to permeabilize the outer membrane.
This indicates that dihydroceramide is able to block the
formation of ceramide channels in mitochondria.
Liposomes are permeabilized by ceramide in a
dose-dependent manner
The release of trapped carboxyfluorescein (CF) from lipo-
somes was monitored by an increase in fluorescence. The
addition of ceramide to liposomes preloaded with CF and
the quencher p-xylene-bis-pyridinium bromide (DPX) leads
to an increase in fluorescence. Permeabilization of the li-
posomes allows the efflux and dilution of the CF and the
quencher resulting in an increase in fluorescence (Figure 3a).
The maximal possible increase was obtained by the addition
of the detergent, Triton-X100.
The amount of CF released depends on the amount of
ceramide added. The larger the amount of C2- (Figure 3b)
or C16-ceramide (Figure 3c) that was added, the greater was
the rate of fluorescence increase and thus the greater the
chance for channels to form and release CF. Considering the
small size of the liposomes and the large size of the ceramide
channels,15,23 once a channel is formed the liposome should
rapidly equilibrate its content with the medium. Thus the
rate of fluorescence increase reflects the rate of channel for-
mation in liposomes.
The greater apparent potency of C2 as compared to C16
is probably due to the problem of delivering ceramide to
the liposome membrane. A smaller fraction of C16-ceramide
partitions into the membrane as compared to C2-ceramide.28
Both DHC2 and DHC16 did not cause permeabilization
when added to liposomes even at concentrations 10 times
higher than the respective ceramides (data not shown).
Dihydroceramide inhibits ceramide channel
formation in liposomes
To test whether mitochondrial proteins might be required to
mediate the dihydroceramide inhibition of ceramide chan-
nel formation, liposome studies were undertaken. Using the
same technique described above, fluorescence increases were
Figure 3 The concentration dependence of ceramide permeabiliza-
tion of liposomes. In panel a, the indicated amount of ceramide was
added after the baseline fluorescence was recorded. The total per-
meabilization of liposomes was achieved with 0.38% Triton-X 100. In
panel b, the concentration dependence of ceramide permeabilization
of liposomes is shown as the percentage of the total fluorescence
increase after Triton addition. Long-chain ceramide (C16) was used
in the experiments illustrated in panel c. Each concentration trace
was the average of at least 3 independent experiments.
monitored following the addition of C2-ceramide (Figure
4a, open symbols) or C2-ceramide premixed with DHC2
(closed symbols). The presence of DHC2 reduced the flu-
orescence increase induced by C2-ceramide addition. Thus
the inclusion of dihydroceramide with ceramide effectively
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Figure 4 Dihydroceramide inhibition of ceramide-induced release
of CF from liposomes. (a) The premixing of dihydroceramide with
ceramide (closed symbols) greatly reduced the release of CF from
liposomes observed with ceramide alone (open symbols). The aver-
age traces of 3 independent experiments are shown. (b) Dihydroce-
ramide inhibited the ceramide-induced permeabilization in liposomes
in a dose-dependent manner. The fluorescence increase following
the addition of 30 nmol ceramide mixed with the values of DHC2
shown was normalized by that induced by 30 nmol ceramide alone.
The results represent the mean of 3 independent experiments ± S.D.
The statistical significance between 2 adjacent points is determined
with ∗, P ≤ 0.05 and ∗∗, P ≤ 0.01.
reduced ceramide channel formation in a dose-dependent
fashion (Figure 4b).
The sequence of addition of ceramide and
dihydroceramide is important for the inhibition
When mitochondria were pretreated with 15 nmoles of ce-
ramide alone to form ceramide channels and then exposed
to 15 nmoles of dihydroceramide, the latter did not reduce
the rate of oxidation of exogenous cytochrome c. Therefore,
during the time allowed, dihydroceramide was not able to
disassemble the channel once it was formed (Figure 5a).
However pre-incubation of mitochondria with 15 nmoles
of dihydroceramide for the indicated times followed by
addition of 15 nmoles of ceramide did inhibit ceramide
Figure 5 Dihydroceramide inhibits the formation of ceramide chan-
nels and does not induce channel disassembly. (a) The initial rate of
cytochrome c oxidation by mitochondria following various treatments:
hypotonic shock (lysed); 15 nmol C2 for 15 min. (C2); 15 nmol DHC2
for 15 min. (DHC2); preincubation with 15 nmoles C2 for 10 min fol-
lowed by 15 nmoles DHC2 for 5 min (C2 then DHC2); preincubation
with 15 nmoles DHC2 for the indicated time followed by 15 nmoles
C2 for the remainder of 15 min (DHC2 then C2). (b) The premixing
of 29 nmol C2 with 22 nmol DHC2 reduced the permeabilization of
liposomes by ceramide. However, the addition of 29 nmol C2 and
29 nmol DHC2 separately but simultaneously (together) had almost
no effect compared to the same amount of C2 alone. Both traces are
the average of 3 experiments each.
channel formation (Figure 5a). This indicates that dihydro-
ceramide interferes with the initiation or nucleation of ce-
ramide channels rather than disassembling them. Figure 5b
shows that premixing 29 nmoles of ceramide and 22 nmoles
of dihydroceramide and adding them together to the lipo-
somes inhibits the release of CF, whereas if they are added
simultaneously but separately there is almost no effect. This
is consistent with the notion that sparingly soluble lipophilic
molecules form aggregates that are fairly stable.29 Adding
ceramide premixed with dihydroceramide leads to aggre-
gates containing both molecules. When these aggregates
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fuse with liposomes, the propensity of ceramide to form
channels is undermined by the presence of dihydroceramide.
When ceramide and dihydroceramide are added at the same
time but using separate pipettes, the tendency of form-
ing mixed aggregates is now much less and the aggregates
of ceramide that fuse with membranes can form channels.
The path dependence of the observations clearly demon-
strates the relatively slow rates of interaction between these
components. It also rules out the possibility that dihydro-
ceramide micelles might interfere with channel formation
by adsorbing ceramide molecules and thus depleting the
available ceramide. Indeed pre-incubating liposomes with
dihydroceramide for up to 5 min prior to ceramide addition
did not change the rate of ceramide channel formation (data
not shown). The dihydroceramide micelles are there but ce-
ramide channels form anyway. These results indicate that
the dihydroceramide inhibition phenomenon is probably
not due to its ability to form micelles that might interfere
non-specifically but rather due to direct interference with
ceramide nucleation and channel formation.
Discussion
Apoptosis occurs normally via two distinct pathways, ex-
trinsic and intrinsic. Apoptosis can be initiated from signals
coming from outside the cell or, alternatively, the signal can
originate within the cell. The permeablization of the mito-
chondrial outer membrane is believed to be the first com-
mitted step in apoptosis since cytochrome c and other inter-
membrane space proteins are released into the cytosol. The
starting phase of the intrinsic pathway of apoptosis is well
characterized; however, the cause of the permeability of the
outer membrane is still debated. The mechanism by which
mitochondria release cytochrome c is still under investiga-
tion and a variety of processes have been proposed.30 In our
model, ceramide-based water-filled pathways, or channels,
in the mitochondrial outer membrane mediate the release of
intermembrane space proteins and initiate apoptosis.23,31
An aqueous pathway through the membrane is both nec-
essary and sufficient to allow the release of cytochrome c
from mitochondria. Cytochrome c is confined between the
mitochondrial outer and inner membranes (the intermem-
brane lumen). Some is in solution and the rest is attached
to the outer surface of the inner membrane.32,33 As a highly
charged (+7) small (13 kDa) globular protein, cytochrome
c is not able to cross membranes spontaneously. The two
pathways across the outer membrane, VDAC and TOM,
are either too small or too highly regulated to facilitate
the translocation of cytochrome c. Ceramides (both long
chain and short chain) have been shown to form large stable
channels in planar membranes.31 C16-ceramide (and other
similar synthetic molecules) were shown to form chloride-
permeant pores in liposomes.34 Moreover, Montes et al.35
showed that ceramide induced permeability in vesicles re-
gardless of the method of delivery (in situ production by
the hydrolysis of sphingomyelin by sphingomyelinase or by
the addition of ceramide from an organic solvent). In addi-
tion, molecular dynamics simulations of ceramide channels
provide some evidence that such channels can be legiti-
mate, stable biological structures (Anishkin et al., personal
communication).
The production of reactive oxygen species (ROS) by ce-
ramide is well documented;16,36,37 however, under our cir-
cumstances such a production should not take place. The
mitochondria are uncoupled by 2,4-dinitrophenol and hence
the protonmotive force is dissipated. Moreover, the mito-
chondria were not supplied with substrates for the respira-
tory complexes and there is no glutathione in the medium.
Under these conditions, ROS production should be minimal
if present. In the cell ceramide can produce ROS and this
may influence the results reported here. However, the results
reported here do not depend on ROS production because we
observed corresponding effects in liposomes. It is evident
that ceramide has multiple roles in the cell and a number of
these contribute to the proapoptotic action of ceramide.
Ceramide metabolism is highly regulated1 in a cell and
ceramide and its metabolites are kept at a steady state level.
When the death signal arrives, ceramide production is in-
creased by de novo synthesis and/or by sphingomyelin hy-
drolysis (for review, see38). One of the products of the de novo
synthesis is dihydroceramide which has been shown to be
inactive both biologically (does not cause apoptosis24,25) and
physically (does not form channels in planar membranes,15
mitochondria23 or liposomes).
During de novo ceramide synthesis,39 serine condenses
with palmitoyl CoA to form ketosphinganine which
is reduced to sphinganine. Dihydroceramide synthase
then produces dihydroceramide from sphinganine and
dihydroceramide desaturase eventually produces ceramide
from dihydroceramide (Figure 6).
Dihydroceramide inhibits ceramide channel formation
both in mitochondria and in liposomes. This attribute of
dihydroceramide may be essential in regulating the effects
of ceramide in cells. In order to permeabilize mitochondria
to start the apoptotic pathway, the synthesized ceramide has
to overcome the inhibition of channel formation by dihy-
droceramide. A threshold ratio of ceramide to dihydroce-
ramide may be a plausible way to think of the initiation of
ceramide-induced apoptosis. Presumably, the formation of
ceramide from de novo synthesis leads to the decline in dihy-
droceramide concentration and hence enhances the ceramide
effects on mitochondria. Possibly, the synthesis of ceramide
by sphingomyelin is less efficient in channel formation be-
cause dihydroceramide concentration is not diminished.40
Moreover, sphingomyelin and sphingomyelinase are mainly
present in the plasma membrane. However, sphingomyeli-
nase added to mitochondria will generate ceramide in mi-
tochondria but this ceramide accumulation was not able to
release cytochrome c.41 In addition there may be a carrier
protein like CERT that shuttles ceramide to mitochondria
in the same way it does from ER to Golgi and plasma
778 Apoptosis · Vol 11 · No 5 · 2006
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Figure 6 A scheme of de novo ceramide synthesis pathway.
membrane.42 Nevertheless, it is quicker and more efficient
to produce ceramide directly in mitochondria by the de novo
pathway in response to a death signal, if the intended target
is to permeabilize mitochondria through ceramide channels.
The de novo pathway has been shown to be the one by which
ceramide is produced in various cell types and as a result of
different stimuli (for review, see43). Furthermore, inhibition
of the de novo enzymes prevented alveolar cell apoptosis.44
When treating cells with tumor necrosis factor, isolated
mitochondria showed a 2-3-fold increase in ceramide lev-
els. This increase was not due to the hydrolysis of sphin-
gomyelin but due to de novo synthesis.36 Cannabinoids, the
active ingredients of marijuana, induced an acute ceramide
synthesis via sphingomyelin hydrolysis, which mediated the
regulation of metabolic functions; and a sustained genera-
tion of ceramide via the de novo pathway. This production
leads to apoptosis.45 In addition, ceramide levels increased
specifically from the de novo synthesis after treating cells
with N-(4-hydroxyphenyl) retinamide, an event that lead to
apoptosis.46 It is clear that the de novo pathway participates
more in ceramide production that induces apoptosis. The
dihydroceramide inhibition of ceramide channel formation
may be another indication of the importance of the de novo
pathway in the regulation of apoptosis.
Conclusion
Ceramide has been shown before to form channels in pla-
nar phospholipid membranes15 and in the outer membrane
of mitochondria.23 These channels allow proteins to cross
membranes and are probably large enough to allow the
known pro-apoptotic proteins to be released from mitochon-
dria. Here, we demonstrate that ceramides (both long chain
and short chain) are able to form channels in liposomes in
a dose-dependent manner. Furthermore, we discovered that
dihydroceramide, generally reported to be an inactive pre-
cursor, inhibits the formation of ceramide channels at a molar
ratio indicative of its interfering with ceramide nucleation of
channel formation. Thus dihydroceramide is probably act-
ing as an inhibitor rather than just being unable to form
channels23 or to cause apoptosis.24,25 We believe that we
have uncovered a regulatory system, not based on enzymatic
activity, that could have a strong influence on the initiation
of the apoptotic process.
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